Percutaneous cryoablation yields outcomes comparable to robotic surgery for renal cancer, at significantly lower cost, Danish ...
Merck and Eisai report Phase 3 results showing Welireg plus Lenvima significantly improved progression-free survival in ...
News-Medical.Net on MSN
TROP2 identified as a promising therapeutic target for renal medullary carcinoma
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...
Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.
Kidney cancer is on the verge of becoming a far larger health problem than it currently is, with cases expected to nearly double by 2050 worldwide. That’s the bleak conclusion in a sweeping survey led ...
A study on kidney cancer rates released in October shows the rate of kidney cancer in Merrimack is 38% higher than in the rest of the state. The research is part of a long-term investigation that ...
Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo versus sunitinib. (HealthDay News) — For patients with advanced renal cell carcinoma (RCC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback